Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

4.39USD
10:56am EDT
Price Change (% chg)

$-0.03 (-0.68%)
Prev Close
$4.42
Open
$4.44
Day's High
$4.45
Day's Low
$4.38
Volume
31,161
Avg. Vol
198,839
52-wk High
$4.86
52-wk Low
$3.35

ATRS.OQ

Chart for ATRS.OQ

About

Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors,... (more)

Overall

Beta: 0.70
Market Cap (Mil.): $557.70
Shares Outstanding (Mil.): 126.18
Dividend: --
Yield (%): --

Financials

  ATRS.OQ Industry Sector
P/E (TTM): -- 27.50 37.76
EPS (TTM): -0.13 -- --
ROI: -25.15 9.26 18.76
ROE: -25.52 12.54 19.59
Search Stocks

UPDATE 1-New U.S. rocket blasts off from Virginia launch pad

* Antares rocket carries dummy cargo capsule on test flight

21 Apr 2013

New U.S. rocket blasts off from Virginia launch pad

- A privately owned rocket built in partnership with NASA to haul cargo to the International Space Station blasted off on Sunday for a debut test flight from a new commercial spaceport in Virginia.

21 Apr 2013

New U.S. rocket blasts off from Virginia launch pad

* Antares rocket carries dummy cargo capsule on test flight

21 Apr 2013

New U.S. rocket cleared for test flight from Virginia spaceport

CAPE CANAVERAL, Florida - A second U.S. company hired by NASA to fly cargo to the International Space Station was cleared to test-fly its Antares rocket from a newly developed commercial spaceport in Virginia, officials said on Tuesday.

16 Apr 2013

New U.S. rocket cleared for test flight from Virginia spaceport

CAPE CANAVERAL, Fla., April 16 - A second U.S. company hired by NASA to fly cargo to the International Space Station was cleared to test-fly its Antares rocket from a newly developed commercial spaceport in Virginia, officials said on Tuesday.

16 Apr 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks